Enzymatically Hydrolyzed Marine Collagen Peptides
3F Pharma’s marine collagen peptides are produced via controlled enzymatic hydrolysis to achieve a low molecular weight profile with high solubility. They are colourless, odourless and tasteless and are more crystalline in structure than powder.
These characteristics support hydrated wound matrices, dermal repair systems, and scaffold-based formulations where diffusion, consistency, and handling are critical.
3F Pharma also supplies marine collagen peptides produced by controlled enzymatic hydrolysis. This process converts collagen into peptide fractions with defined and reproducible material characteristics.
The collagen peptides are supplied as a raw material and are suitable for use in research, cosmetic, nutraceutical, and biomedical material development applications where hydrolyzed collagen peptides are required.
3F Peptides Performance vs. Industry Leader
Key material characteristics
- >98% purity
- Average molecular weight ~3 kDa
- Controlled polydispersity (~1–6 kDa)
- High solubility in aqueous systems
- Odourless, colourless, tasteless
- Commercial-scale production protocol delivers >20kg dry peptides per batch run
Primary applications
- Wound care & dermal repair (wound gels, matrices, dressings)
- Dermal & skin science (biomedical + cosmetic R&D)
- Scaffold-based systems & cellular agriculture
- Food ingredient and nutraceuticals
Bioavailability-relevant material characteristics
The low molecular weight and controlled distribution result in high solubility and diffusivity in hydrated systems. Such characteristics are widely discussed in the literature as relevant considerations during bioavailability and delivery research, depending on formulation and application context.
Request technical information
Contact us to request specifications, data sheets, and application guidance.